Siemens Healthineers has teamed up with the recently rebranded drugmaker Novo on a project to advance its blood test for hidden liver disease, in a bid to deliver earlier diagnoses and access to treatment. Aimed at the category of metabolic dysfunction-associated steatotic liver disease, or MASLD — and its progressive stage, metabolic dysfunction-associated steatohepatitis, commonly […]
